608
HETEROCYCLES, Vol. 77, No. 1, 2009
38.41, 56.00, 56.66, 66.38, 91.22, 105.11, 111.45, 155.51, 157.69, 159.45, 160.35, 161.25. HREIMS
m/z 374.0013 (Calcd for C14H15IO4: 374.0015).
(3R*,4R*)-7-Acetoxy-3,4-dihydroxy-4-isopropylchroman-2-one (10b) (Run 4 in Table 1)
Identical procedure for the synthesis of 11 and 12 was applied with 9b (901 mg, 3.66 mmol), CeCl3·7H2O
(139 mg, 0.37 mmol), NaIO4 (1.17 g, 5.48 mmol), and 0.1 M aq. RuCl3 (0.10 mL, 10 μM) in AcOEt -
MeCN - H2O (3 :3 :1, 12.6 mL) to give 10b (906 mg, 88%) after the purification by CC (hexane - AcOEt
= 3 :1 to 1 :1). An aliquot was recrystallized from hexane - acetone (15 : 1) to give an authentic sample.
Colorless prisms. mp 132.5-134 °C. Anal. Calcd for C14H16O6: C: 59.99, H: 5.75. Found: C: 59.61,
H: 5.73. IR (cm-1): 3464 (OH), 1759 (C=O). 1H-NMR (CDCl3) δ (ppm): 1.07, 1.11 (each 3H, d, J =
7.1 Hz, 2 x Me), 2.31 (3H, s, Ac), 2.33 (1H, sep, J = 7.1 Hz, CH), 2.78, 3.26 (each 1H, s, 2 x OH,
exchangeable with D2O), 4.53 (1H, s, 3-H), 6.89 (1H, d, J = 2.4 Hz, 8-H), 6.98 (1H, dd, J = 8.6, 2.4 Hz,
6-H), 7.56 (1H, d, J = 8.6 Hz, 5-H). 13C-NMR (100 MHz) δ (ppm): 16.72, 16.91, 21.00, 34.02, 71.06,
75.42, 110.44, 117.92, 123.35, 128.17, 149.78, 141.12, 168.53, 169.35. EIMS m/z 281 [(M+1)+, 13%],
262 (11%), 207 (100%).
(3R*,4R*)-3,4-Dihydroxy-4-propyl-2-oxo-2H-chromen-7-yl p-toluenesulfonate (10c) (Run 5 in Table 1)
Identical procedure for the synthesis of 11 and 12 was applied with 9c (1.00 g, 2.80 mmol), CeCl3·7H2O
(108 mg, 0.29 mmol), NaIO4 (896 mg, 4.19 mmol), and 0.1 M aq. RuCl3 (70 μL, 7.0 μM) in AcOEt -
MeCN - H2O (3 : 3 : 1, 14 mL) to give 10c (1.04 g, 95%) after the purification by CC (hexane - AcOEt 3 :
1 to 1 :1). An aliquot was recrystallized from benzene to give an authentic sample.
Colorless prisms. mp 145-146.5 °C. Anal. Calcd for C19H20O7S: C: 58.15, H: 5.14. Found: C: 58.19,
H: 5.20. IR (cm-1) 3543, 3469 (OH), 1745 (C=O). 1H-NMR (CDCl3) δ (ppm): 1.03, 1.06 (each 3H, d,
J = 7.0 Hz, 2 x Me), 2.25 (1H, sep, J = 7.0 Hz, CH), 2.47 (3H, s, Me), 2.79 (1H, s, OH, exchangeable
with D2O), 3.24 (1H, d, J = 3.3 Hz, OH, exchangeable with D2O), 4.50 [1H, d (s with D2O), J = 3.3 Hz,
3-H], 6.72 (1H, d, J = 2.4 Hz, 8-H), 6.94 (1H, dd, J = 8.6, 2.4 Hz, 6-H), 7.34 (2H, d, J = 8.1 Hz, Ts-meta),
7.50 (1H, d, J = 8.6 Hz, 5-H), 7.75 (2H, d, J = 8.1 Hz, Ts-ortho). 13C-NMR (100 MHz) δ (ppm): 16.70,
17.06, 21.72, 33.95, 70.93, 75.31, 111.17, 118.74, 124.43, 128.36, 128.40, 129.94, 132.05, 145.85, 149.87,
150.00, 168.26. EIMS m/z 392 (M+, 20%), 374 (12%), 349 (25%), 219 (32%), 155 (89%), 91 (100%).
3-Hydroxy-7,8,9,10-tetrahydrobenzo[c]chromen-6-one (16a)
Identical procedure for the synthesis of 9a was applied with 7 (1.00 g, 9.12 mmol), 15 (2.01 g, 10.3
mmol) and conc. H2SO4 (2.0 mL) to give 16a (2.02 g, quant).
Pale pink solid. mp 205-208 °C (lit.,14 203-204°C). IR (cm-1) 3452 (OH), 1738 (C=O). 1H-NMR
(DMSO-d6) δ (ppm): 1.73-1.79 (4H, m, 8,9-H2), 2.41 (2H, t, J = 6.0 Hz, 10-H2), 2.76 (2H, t, J = 6.0 Hz,